The following institutes and organisations are involved in the Eurocadet project:

• Department of Public Health, Erasmus MC, Rotterdam, the Netherlands
• International Agency for Research on Cancer (IARC), Lyons, France
• Institut Catala d'Oncologia (ICO), Spain
• Abt. Klinische Epidemiologie und Alternsforschung, Deutsches Krebsforschungszentrum, Heidelberg, Germany
• Azienda Sanitaria Regionale (Asl-5), Turin, Italy
• Finnish Cancer Registry (FCR), Helsinki, Finland
• University of Oslo (UOSLO), Oslo, Norway
• Institute of Cancer Research and Cure (INT), Milan, Italy
• Danish Cancer Society (DCS), Copenhagen, Denmark
• National and Kapodistrian University of Athens (NKUA), Athens, Greece
• Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (COI), Warsaw, Poland

 

 

 

 

 

 

 

 

 

 

 

Department of Public Health, Erasmus MC, Rotterdam, the Netherlands (Erasmus MC)
Coordinator centre of Eurocadet, the Department of Public Health hosts 4 work packages (Work Packages 1, 3, 4 and 7).
Jan Barendregt, PhD, has expertise in epidemiological modelling of disease processes and in the projection of disease occurrence in relation to risk factors. He developed the Prevent model, that takes time lags between exposure and disease occurrence and changes in the prevalence of risk factors into account. Prevent will be used to make long-term predictions in WP 7 after being tested and adapted in WP1. Jan Barendregt is involved in the work packages 1 and 7 as advisor, also for the regional workshops.
Johannes Brug, PhD, health scientist, since 2002 Professor of Determinants of Public Health at the Erasmus MC and of Nutrition Education at Dept of Health Sciences at Maastricht University. His research is focussed on predicting and explaining health-related behaviour and on planned development and evaluation of health promotion interventions. He is member of the International Scientific Food Choice Series group and the International Society of Behaviour Nutrition and Physical Activity and is one of the principal investigators in the EU FP5-funded Pro Children project aimed at explaining and promoting fruit and vegetable intake among children. He is leader of WP 4 and will also be closely involved with WP 5 and scenariodevelopment in WP7.
Jan Willem Coebergh, MD, PhD is a public health physician-cancer epidemiologist and Professor of Cancer Surveillance at the department of Public Health since June 2005. He is also part-time Head of Research at the Eindhoven Cancer Registry of the Comprehensive Cancer Centre South.  He has experience in Cancer Control over the past 20 years, including projections of the future burden of Cancer in the Netherlands 1990-2015. He will be responsible for the 2 coordinating and synthesising workpackages (1 and 7) and be the main project leader.
Anton E. Kunst, PhD is Assistant Professor at the Dept of Public Health of Erasmus MC. He obtained a Master in Demography (University of Groningen) and a holds a PhD from the Erasmus University Rotterdam. His main research interest is with socio-economic inequalities in mortality, morbidity and health service use. He is leader of WP 3.
Johan Mackenbach, MD, PhD, is Professor of Public Health and Head of the Department of Public Health. His research interests are in the fields of epidemiology, demography and health services research. He teaches public health and epidemiology at the Netherlands School of Public Health and at the Netherlands Institute for Health Sciences, a member of the Health Council and the Health Research Council in the Netherlands, editor of the European Journal of Public Health and co-ordinates a number of European networks, including the European Network of Interventions and Policies to Reduce Inequalities in Health.

International Agency for Research on Cancer, Lyons, France (IARC)
Host Institute of 2 work packages (Work Packages 2 and 6). The Descriptive Epidemiology Group is the main contributing group of this institute.
Philippe Autier, MD received his medical degree from the Free University of Brussels in 1982. He worked in the field of international health for 4 years, after which he was appointed Head of the Medical Department of Doctors Without Borders. He was one of the founders of the European Agency for Development and Health in Brussels. In 1989 he obtained a Masters in Public Health, specializing in Epidemiology, from Harvard University, USA. After that he worked four years as a physician and head epidemiologist at the Jules Bordet Institute and the Belgian Cancer Organization, now the Belgian Federation Against Cancer. In 1995 he became Deputy Director of the Epidemiology and Biostatistics Department at the European Institute of Oncology in Milan. Between 2000 and 2005 he returned to Brussels as Head of the Centre of Epidemiology and Statistics at the Luxembourg Institute for Health and Head of the Unit of Epidemiology and Prevention at the Jules Bordet Institute. Philippe has been with IARC, based in Lyon, France, since 2005, as Head of the Biostatistics and Epidemiology Cluster. Philippe Autier, in addition to being a specialist in the diagnosis of skin cancers and the early diagnosis of cancers also has great expertise in the fields of public health related to reproductive and hormonal factors. Additionally, he is a member of multiple international scientific associations interested in cancer research and international health.
Mathieu Boniol, Phd, a bio-statistician epidemiologist, graduated from the University of Bourgogne in 2004. He has been working with the International Agency for Research on Cancer since 2001, through collaborative projects and publications, mainly in the field of the epidemiology of melanoma cancer risk factors and distribution among the world population and also on the European Cancer Mortality Atlas (1993-1997). He completed his post-doctorate (2004-2006) and was part of several IARC Working Groups, including Attributable causes of cancer, Exposure to artificial ultraviolet light and risk of skin cancer and Cancer following the Chernobyl Accident. In addition, he actively participated in research on melanoma epidemiology within the EORTC melanoma group.
Murielle Colombet, Msc joined the International Agency for Research on Cancer as a statistician in January 2007. She has a diploma from the University of Lyon with a double specialization in Mathematics and Statistics. Her role consists of analyzing the figures and data collected in the framework of the Eurocadet Project, to make sure that the data meet the fairest assessment of established human cancer risk factors in Europe.
 

Institut Catala d'Oncologia, Spain (ICO)
Josep Borràs, MD, epidemiologist, heads the Catalan Institute of Oncology and has performed a number of studies on cancer mortality in Europe and Spain and changes in smoking patterns in Spain. He will liaise with cancer prevention activities in Spain and host the regional workshop on Prevent for southern Europe in WP 7.

Deutsches Zentrum für Alternsforschung, Heidelberg, Germany (DZFA)
Herman Brenner, MD, epidemiologist, heads the Center of the Study of Ageing in Heidelberg; he has a wide experience in cancer epidemiology in the field of etiological and prognostic studies and in the domain of modeling of incidence. He will also liaise to ongoing German prevention activities, widely varying within the country, that have large effects on the health of the elderly. He will also host the regional workshop on scenario development with Prevent for middle (German speaking) Europe during WP 7.

Azienda Sanitaria Regionale, Turin, Italy (ASL-5)
Giuseppe Costa, MD, Professor at dept of Public Health and Microbiology of the University of Torino, has wide expertise in the study of the role of SES in cancer mortality; he will actively assist in the analyses conducted for WP 3. He will also be involved in the process of defining the role of SES and SES-differences on cancer incidence and exposures also by means of interventions (WP 5) and for scenario development in WP 7.

Finnish Cancer Registry, Helsinki, Finland (FCR)
Eero Pukkala, PhD, senior researcher at the Finnish cancer registry, has a broad experience in registry-based studies and cancer etiology in Finland and in Northern Europe, including the role of SES. Was involved in the Scandinavian study of avoidable cancers. He will be strongly involved in WP 1 by letting the researcher of WP1 have maximal benefit from the wide availability of relevant data in Finland and/or Scandinavia; will also be involved in WP 3 and in scenario development in WP 7.

University of Oslo, Oslo, Norway (UOSLO)
Host of 1 work package (Work Package 5).
Knut-Inge Klepp, Professor of Public Health Nutrition and Health Promotion Research at the University of Oslo. His research is focussed on predicting and explaining health-related behaviour among children and adolescents and on evaluation of health promotion interventions. Coordinates EU FP5-funded Pro Children project on promoting fruit and vegetable intake among children in Europe. Executive member of the International Society of Behavioral Nutrition and Physical Activity, and of the WHO-Europe- expert group on research in behavioural and social sciences to improve cancer control. He is the chair person of the Norwegian National Council for Nutrition. He will closely evaluate the outcome of WP4 as input for his work package (6).

Institute of Cancer Research and Cure, Milan, Italy (INT)
Andrea Micheli, PhD, Italy, is a medical sociologist who as a project leader of Eurochip II (in 2004-07) will ensure a proper flow of information between (emerging) health information for the selected indicators of prevention and scenario development for prevention. He will give a substantial contribution to choosing the indicators to be used in the project in WP1 and in scenario development in WP7. He will also give advise in WP 3,4 and 5.

Office for National Statistics, London, United Kingdom (ONS)
Mike Quinn, PhD, is Director of the National Cancer Intelligence Centre at the Office of National Statistics in London. He was involved in drawing the European Code against Cancer and coordinated the work on the prediction of cancer mortality across Europe up till 2015. He will also liaise with ongoing cancer prevention programmes in the UK, will be involved in WP3, supervise the predictive modeling in WP6 and organize a workshop on scenario development for the United Kingdom in WP 7.

Danish Cancer Society, Copenhagen, Denmark (DCS)
Hans Storm, MD, PhD, Director of Cancer Prevention and Documentation at the Danish Cancer Society, has a wide experience with cancer registration processes within the Danish Cancer Registry and its oncological constituancy; he is since 1997 responsible for cancer prevention in Denmark with a broad program of action research e.g. on smoking cessation, fruit consumption and obesity and physical exercise. He was involved in the European Cancer Code. He will have specific input in the WP’s 1, and especially 5 based on his broad policy knowledge. During WP 7 he will host the regional workshop on Prevent for Scandinavia and the UK.
Anne Tjønneland, MD, PhD, senior researcher, has extensive knowledge about and experience with methods for dietary assessment in epidemiological studies. Since 1996 she is the head of the ‘Diet, Cancer and Health program’ and since January 2001 she is the head of the programmes in the Institute of Cancer Epidemiology at the Danish Cancer Society. She has been a member of many expert committees on diet, weight control, physical activities, alcohol intake, fruit and vegetables and antioxidants. She will interpret and comment reviewing work concerning the impact of prevention, especially on obesity and physical activity and as such will contibute to work packages 1,2,4,5 and 7.

National and Kapodistrian University of Athens, Athens, Greece (NKUA)
Antonia Trichopoulou, PhD, Greece, is an expert in the study of dietary variation across Europe. She will assist in providing the right information on dietary exposures and food interventions and be involved in WP 2,4,5 and 7; she will liaise with preventive activities in Greece.

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (COI)
Witold Zatonski, MD, PhD: professor at the Oncology Centre in Warsaw. He will liaise with cancer preventive activities in Poland and in other countries of Eastern Europe to aid scenario development. His department is a WHO Collaborating Center for a Tobacco Free Europe. He is keenly aware of all aspects of smoking avoidance as Regional Coordinator for Tobacco Control. Is also part of the Eurodiet Network and broadly involved in research of determinants of premature death, and intervention activities to reduce morbidity and mortality from chronic disease, comprising cancer in Eastern Europe. Within WP 7 he will host a regional workshop on Prevent for Eastern Europe.